Microvesicle-based Solutions for Industrial, Environmental, and Personal Care Applications

The present inventive concept leverages the core technology of therapeutic microvesicles of probiotic bacteria to address pressing challenges in industrial wastewater treatment, indoor air quality, personal care, agriculture, and disease diagnosis.

The original patent focused on therapeutic microvesicles for human health. However, the potential of this technology extends far beyond healthcare. The inventive concept tackles the limitations of the original patent by applying the microvesicle technology to new, high-impact areas, where existing solutions are inadequate or non-existent.

The new claims encompass methods and systems for utilizing therapeutic microvesicles in industrial wastewater treatment to break down organic pollutants, in indoor air quality monitoring to detect and neutralize airborne pathogens, in personal care products for skin and hair care applications, in agriculture to enhance crop yields and disease resistance, and in diagnostics to detect biomarkers for early disease diagnosis. These applications harness the unique properties of microvesicles to provide innovative solutions.

The inventive concept's novelty lies in its application of microvesicle technology to entirely new fields, leveraging the original patent's core principles to address distinct problems. The inventive step resides in the unexpected yet effective use of microvesicles in these novel contexts.

Alternative embodiments may include variations in microvesicle composition, size, or surface modification to optimize their performance in different applications. Additionally, the use of different probiotic bacterial strains or combinations thereof could expand the range of potential applications.

The inventive concept has significant commercial potential across multiple industries, including industrial wastewater treatment, air quality monitoring, personal care, agriculture, and diagnostics. The market for these applications is substantial, with opportunities for partnerships, licensing, and product development.